Plexus Corp. (NASDAQ:PLXS) Stock Has Consensus Price Target of $276.86

Plexus Corp. (NASDAQ:PLXS – Get Free Report) has received a consensus recommendation of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $276.86.

Several research firms have recently weighed in on PLXS. Needham & Company LLC reiterated a “buy” rating and issued a $310.00 price objective on shares of Plexus in a research note on Friday, August 14th. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a research report on Friday, July 31st. Raymond James Financial restated an “outperform” rating on shares of Plexus in a research note on Friday. Fox Advisors raised Plexus from an “equal weight” rating to an “overweight” rating in a research report on Monday, November 2nd. Finally, Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research note on Sunday, November 1st.

Check Out Our Latest Stock Report on PLXS

Plexus Stock Performance

Shares of NASDAQ:PLXS opened at $206.10 on Thursday. The company’s 50 day moving average price is $238.87 and its two-hundred day moving average price is $240.99. Plexus has a 12-month low of $132.03 and a 12-month high of $307.06. The firm has a market cap of $5.51 billion, a PE ratio of 27.78 and a beta of 0.97. The company has a quick ratio of 0.67, a current ratio of 1.43 and a debt-to-equity ratio of 0.05.

Plexus (NASDAQ:PLXS – Get Free Report) last released its earnings results on Wednesday, October 28th. The technology company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.55 by $0.29. Plexus had a return on equity of 13.34% and a net margin of 4.08%. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the prior year, the company earned $2.14 earnings per share. The company’s quarterly revenue was up 34.9% on a year-over-year basis. Equities research analysts predict that Plexus will post 9.02 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Todd Kelsey sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the completion of the transaction, the chief executive officer directly owned 65,888 shares of the company’s stock, valued at $16,536,570.24. This represents a 2.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $240.87, for a total transaction of $120,435.00. Following the completion of the transaction, the director directly owned 7,535 shares in the company, valued at $1,814,955.45. This trade represents a 6.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 5,000 shares of company stock worth $1,219,260. 1.78% of the stock is owned by company insiders.

Institutional Investors Weigh In On Plexus

Several institutional investors have recently made changes to their positions in PLXS. BlackRock Inc. bought a new position in shares of Plexus during the second quarter valued at approximately $1,311,631,000. Congress Asset Management Co. lifted its holdings in Plexus by 204.0% during the third quarter. Congress Asset Management Co. now owns 315,396 shares of the technology company’s stock worth $82,303,000 after buying an additional 211,663 shares during the period. Bank of America Corp DE bought a new stake in Plexus during the 2nd quarter valued at $60,281,000. Bank of New York Mellon Corp bought a new stake in Plexus during the 2nd quarter valued at $55,525,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Plexus in the 2nd quarter valued at $35,755,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. is a provider of electronics manufacturing services and product realization solutions for companies that develop complex products. Its services span product design and development, engineering, manufacturing, supply chain management, fulfillment, and aftermarket support. The company serves customers in markets including healthcare and life sciences, industrial, and aerospace and defense. Its work supports products that may require specialized engineering, quality controls, and production processes.

Featured Stories

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.